VialCapsulesGLP-1 & Metabolic

Semaglutide (GLP-1)

Name: Semaglutide (GLP-1)
Brand: Prime Bio Group

The original GLP-1 receptor agonist — the reference compound in metabolic research, now also available as an oral capsule and as a co-formulation with BPC-157.

For research use only · not for human consumption

7mg vial$125Order at Prime →

12mg vial$175Order at Prime →

24mg vial$240Order at Prime →

7mg:2mg GLP-1:BPC-157 vial$225Order at Prime →

30 capsules (7mg)$115Order at Prime →

View Semaglutide (GLP-1) at Prime Bio Group →

Orders are placed, processed, and shipped by Prime Bio Group. Fresno Peptide Lab does not stock or sell product — we may earn a commission at no extra cost to you.

Independent research on Semaglutide (GLP-1). Our sister publication Peptides Uncaged maintains a plain-English research guide covering mechanism, the published literature, and how vendors are scored on purity and COA transparency. It is written independently of any lab. How to read a COA is worth ten minutes before your first order.

The research

What Semaglutide (GLP-1) is being studied for

GLP-1 is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management. GLP-1 acts like human glucagon-like peptide-1 in that it increases insulin secretion, thereby increasing sugar metabolism. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.

Weight loss may result from GLP-1’s reduction of appetite and slowing down digestion. This was a global study of nearly 2000 individuals with a BMI of 30 or greater, or BMI of 27 or greater and coexistent hypertension, dyslipidemia, sleep apnea, or cardiovascular disease. The treatment group received subcutaneous injections of GLP-1, the control a placebo injection; both groups received “lifestyle interventions.” The outcomes of interest were weight loss as measured as a percent change from baseline and achieving a 5% or greater reduction in body weight over 68 weeks.

Adverse Reactions may include: gastrointestinal – nausea, vomiting, diarrhea, and constipation. SEMAGLUTIDE SEMAGLUTIDE BPC-157 COA.

Summary of published preclinical and clinical literature, provided for research context only. Not a claim of efficacy and not medical advice.

Common questions

Semaglutide (GLP-1) — FAQ

What is Semaglutide (GLP-1)?

The original GLP-1 receptor agonist — the reference compound in metabolic research, now also available as an oral capsule and as a co-formulation with BPC-157.

What formats does Semaglutide (GLP-1) come in?

Prime Bio Group supplies Semaglutide (GLP-1) as vial and capsules. Available options: 7mg vial at $125; 12mg vial at $175; 24mg vial at $240; 7mg:2mg GLP-1:BPC-157 vial at $225; 30 capsules (7mg) at $115.

Is there a certificate of analysis for Semaglutide (GLP-1)?

Yes. Prime Bio Group is a physician-owned lab and provides a certificate of analysis on every batch. A COA reports identity by mass spectrometry and purity by HPLC — if you are not sure how to read one, our guide on reading a certificate of analysis walks through it line by line.

Also in GLP-1 & Metabolic